These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23205537)

  • 1. Hyperpigmentary disorders: a therapeutic challenge in the dermatological practice.
    Zielinski Y
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():1. PubMed ID: 23205537
    [No Abstract]   [Full Text] [Related]  

  • 2. The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches.
    Gillbro JM; Olsson MJ
    Int J Cosmet Sci; 2011 Jun; 33(3):210-21. PubMed ID: 21265866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined topical delivery and dermalinfusion of decapeptide-12 accelerates resolution of post-inflammatory hyperpigmentation in skin of color.
    Bhatia A; Hsu JTs; Hantash BM
    J Drugs Dermatol; 2014 Jan; 13(1):84-5. PubMed ID: 24385124
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
    Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
    Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimelanogenic and antioxidative properties of Bifidobacterium bifidum.
    Huang HC; Huang WY; Chiu SH; Ke HJ; Chiu SW; Wu SY; Kuo FS; Chang TM
    Arch Dermatol Res; 2011 Sep; 303(7):527-31. PubMed ID: 21365207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical hydroquinone in the treatment of some hyperpigmentary disorders.
    Amer M; Metwalli M
    Int J Dermatol; 1998 Jun; 37(6):449-50. PubMed ID: 9646135
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypopigmenting activity of bisabolangelone isolated from Angelica koreana Maxim. in α-melanocyte stimulating hormone-activated B16 or melan-a cells.
    Roh E; Yun CY; Lee JW; Lee C; Hwang BY; Oh ST; Jung SH; Han SB; Kim Y
    Planta Med; 2011 Feb; 77(3):248-51. PubMed ID: 20814852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging.
    Fabi S; Massaki N; Goldman MP
    J Drugs Dermatol; 2012 Aug; 11(8):964-8. PubMed ID: 22859242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical methimazole as a new treatment for postinflammatory hyperpigmentation: report of the first case.
    Kasraee B; Handjani F; Parhizgar A; Omrani GR; Fallahi MR; Amini M; Nikbakhsh M; Tran C; Hügin A; Sorg O; Saurat JH
    Dermatology; 2005; 211(4):360-2. PubMed ID: 16286748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin-lightening agents: new chemical and plant extracts--ongoing search for the Holy Grail!
    Kanthraj GR
    Indian J Dermatol Venereol Leprol; 2010; 76(1):3-6. PubMed ID: 20061723
    [No Abstract]   [Full Text] [Related]  

  • 11. A new tyrosinase inhibitor from Crinum yemense as potential treatment for hyperpigmentation.
    Abdel-Halim OB; Marzouk AM; Mothana R; Awadh N
    Pharmazie; 2008 May; 63(5):405-7. PubMed ID: 18557429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of action and clinical benefits of soy for the treatment of hyperpigmentation.
    Leyden J; Wallo W
    Int J Dermatol; 2011 Apr; 50(4):470-7. PubMed ID: 21332714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torilin from Torilis japonica inhibits melanin production in alpha-melanocyte stimulating hormone-activated B16 melanoma cells.
    Yun CY; Kim D; Lee WH; Park YM; Lee SH; Na M; Jahng Y; Hwang BY; Lee MK; Han SB; Kim Y
    Planta Med; 2009 Nov; 75(14):1505-8. PubMed ID: 19533579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hyperpigmentation.
    Woolery-Lloyd H; Kammer JN
    Semin Cutan Med Surg; 2011 Sep; 30(3):171-5. PubMed ID: 21925372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of 5-chloroacetyl-2-piperidino-1,3-selenazole, a novel selenium-containing compound, on skin melanin biosynthesis.
    Lee EH; Lim YJ; Ha SK; Kang TH; Koketsu M; Kang C; Kim SY; Park JH
    J Pharm Pharmacol; 2010 Mar; 62(3):352-9. PubMed ID: 20487219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperpigmentation: types, diagnostics and targeted treatment options.
    Nieuweboer-Krobotova L
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():2-4. PubMed ID: 23205538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology of hyperpigmentation syndromes.
    Speeckaert R; Van Gele M; Speeckaert MM; Lambert J; van Geel N
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):512-24. PubMed ID: 24612852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new type of tyrosinase inhibitors from natural products as potential treatments for hyperpigmentation.
    Badria FA; elGayyar MA
    Boll Chim Farm; 2001; 140(4):267-71. PubMed ID: 11570225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case reports: minocycline-induced hyperpigmentation resolves during oral isotretinoin therapy.
    Soung J; Cohen J; Phelps R; Cohen SR
    J Drugs Dermatol; 2007 Dec; 6(12):1232-6. PubMed ID: 18189065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depigmenting and bleaching agents: coping with hyperpigmentation.
    Katsambas AD; Stratigos AJ
    Clin Dermatol; 2001; 19(4):483-8. PubMed ID: 11535393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.